Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein
P Proost1, J Van Damme, G Opdenakker
1Rega Institute for Medical Research, University of Leuven, Belgium.
Abstract:
Gelatinase B, a marker enzyme for chronic inflammatory diseases such as rheumatoid arthritis and multiple sclerosis (MS), was found to cleave human myelin basic protein (MBP). Human MBP was digested with gelatinase B from leukocytes. The MBP peptide fragments were separated by RP-HPLC and the gelatinase B cleavage sites established by aminoterminal sequence analysis. Several novel P1-P1' cleavage sites for gelatinase B were found. The positions of the cleavage sites in human MBP were such that at least one peptide coincided with a documented major MBP-autoantigen. This study annotates human MBP as a substrate for human gelatinase B, determines novel P1-P'1 cleavage sites and defines one of the metalloproteinases as a possible link in the pathogenesis of demyelinating diseases such as MS.
Insights
Gelatinase B, an enzyme linked to inflammatory diseases, cleaves human myelin basic protein (MBP). This cleavage generates fragments that may contribute to the development of demyelinating diseases like multiple sclerosis (MS).
Area of Science:
- Biochemistry
- Immunology
- Neuroscience
Background:
- Gelatinase B is a key enzyme in chronic inflammatory diseases, including rheumatoid arthritis and multiple sclerosis (MS).
- Myelin basic protein (MBP) is a critical component of the myelin sheath and a known autoantigen in demyelinating diseases.
Purpose of the Study:
- To investigate whether gelatinase B can cleave human myelin basic protein (MBP).
- To identify the specific cleavage sites of gelatinase B on human MBP.
- To explore the potential role of this interaction in the pathogenesis of demyelinating diseases.
Main Methods:
- Digestion of human MBP using gelatinase B isolated from leukocytes.
- Separation of MBP peptide fragments using reversed-phase high-performance liquid chromatography (RP-HPLC).
- Determination of gelatinase B cleavage sites through aminoterminal sequence analysis.
Main Results:
- Gelatinase B was confirmed to cleave human MBP.
- Several novel P1-P1' cleavage sites for gelatinase B on human MBP were identified.
- At least one resulting peptide fragment corresponded to a known major MBP-autoantigen.
Conclusions:
- Human MBP is a substrate for human gelatinase B.
- Novel cleavage sites for gelatinase B on MBP were defined.
- Gelatinase B represents a potential link in the pathogenesis of demyelinating diseases, such as MS.
More Related Videos
09:46Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
Published on: September 21, 2021
10:50Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
Published on: March 26, 2019
Related Concept Videos
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
